Henry Schein Dental (HSIC) - Price to Earnings Ratio

Corporate emblem and logo of Henry Schein Corp (HSIC)

Henry Schein, Inc. (HSIC) management is restoring operational efficiency following a cyberattack, which confirms the company's value-to-earnings trend. The 23.60 metric reflects current dynamics as experienced executives implement a market consolidation strategy. Stable cash flow is driven by uninterrupted supplies to the dental sector, guaranteeing the business a predictable capital inflow and resilience.

HSIC henryschein.com: P/E Multiple in the range 07/04/2022 - 11/12/2026

Analytical breakdowns for Henry Schein, Inc.

- price and consensus price forecast:
Stock Price henryschein.com|HSIC - Analyst Consensus Forecast
- market capitalization indicators:
Market Valuation Henry Schein, Inc.|HSIC - Real Price to Acquire Entire Company
- balance sheet equity data:
Net Asset Value per Share Henry Schein|HSIC - Book Capitalization|Market Value to Book Value henryschein.com|HSIC - Company Total Assets
- debt obligations and liquidity statistics:
Debt to Capital Henry Schein, Inc.|HSIC - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Henry Schein Dental|HSIC - Company Debts|Debt to Net Assets Ratio Henry Schein, Inc.|HSIC - Company Long-Term Liabilities|Short-Term Debt Henry Schein|Intermediate Coverage Ratio henryschein.com
- business earnings and investment ratios data:
HSIC - Company Net Income|Company Profit Forecast Henry Schein, Inc.|HSIC - P/E Multiple|Projected Price to Earnings Henry Schein Inc|HSIC - PEG Multiple|Business Value to Operating Income Before Depreciation Henry Schein, Inc.|HSIC - Operating profit EBITDA|Net earnings per one share for the last twelve months Henry Schein|HSIC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months henryschein.com|HSIC - Earnings per share growth in current year|Projected earnings per share growth rate for next year Henry Schein, Inc.
Comprehensive company analysis:henryschein.com - HSIC
Original product of henryschein.com

Market expectations for Henry Schein, Inc. (HSIC) are based on the stability of global medical technology and consumable supplies, which determines the business's investment attractiveness. The relationship between share prices and net income, reflected by the company's market P/E ratio, measures the capital payback period, allowing investors to differentiate the asset's fair value from a critical loss of confidence in the distribution operating model.

Competing companies

P/E Multiple CVS Corp|P/E Multiple MCK|Price to Earnings Ratio Cencora Inc COR|Cardinal Health Corp - Price to Earnings Ratio|Prestige Corp (PBH) - Market Cap to Earnings|Wellgistics - P/E Multiple|Company Value to Net Income YI (111, Inc.)|RDGT: P/E Multiple|Market Cap to Earnings Universe Pharmaceuticals Inc. (UPC)|Price to Earnings Ratio Biodexa|Price to Earnings Multiple HKPD (HK Pharma Digital)|Price to Earnings Ratio BIMI Holdings Inc. (BIMI)|CJJD (jiuzhou-drugstore.com) - Company Value to Net Income|Walgreens Boots Alliance, Inc. - Price to Earnings Ratio